FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Biomedic Labs Johnson Memorial Cancer Center, and Orgen Nutraceuticals.

Senate Hearing on Califfs Nomination Set for 11/17

[ Price : $8.95]

The Senate Health, Education, Labor and Pensions Committee sets an 11/17 hearing to review the nomination of FDA deputy commission...

Serious Sterile Drug Deficiencies at Johnson Memorial

[ Price : $8.95]

FDAs New England District Office warns Johnson Memorial Cancer Center about serious deficiencies in its production of sterile drug...

FDA: Company Distributing 5 Unapproved New Drugs

[ Price : $8.95]

FDAs Los Angeles District Office warns Biomedic Labs that it is distributing unapproved new drugs through two Web sites.

Califf Praises FDA Staff

[ Price : $8.95]

FDA commissioner nominee Robert Califf praises the intensity of mission and dedication of the agency staff during a conference app...

FDA Accepts Revision Optics PMA for Vision Inlay

[ Price : $8.95]

FDA accepts for review a ReVision Optics PMA for the Raindrop Near Vision Inlay, a microscopic hydrogel inlay designed to correct ...

Law Firm Touts Preemption Court Win

[ Price : $8.95]

Kaye Scholer says an Illinois federal judge ruled that multi-district litigation testosterone replacement therapy claims against A...

FDA Wants Better Funding Predictability in Next PDUFA

[ Price : $8.95]

FDA says the next Prescription Drug User Fee Act program should have better funding predictability.

FDA OKs Genentechs Cotellic for Melanoma

[ Price : $8.95]

FDA approves a Genentech NDA for Cotellic (cobimetinib) and its use in combination with the companys Zelboraf (vemurafenib) to tre...

Interventional Spine Next-gen Opticage Spinal Device Cleared

[ Price : $8.95]

FDA clears an Interventional Spine 510(k) for its Opticage Expandable Interbody Fusion Device, an enhanced version of its 2012-cle...